GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Aflac Inc (BSP:A1FL34) » Definitions » Research & Development

Aflac (BSP:A1FL34) Research & Development : R$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Aflac Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aflac's Research & Development for the three months ended in Mar. 2025 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was R$0 Mil.

Aflac Research & Development Historical Data

The historical data trend for Aflac's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aflac Research & Development Chart

Aflac Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aflac Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aflac Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aflac  (BSP:A1FL34) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aflac Research & Development Related Terms

Thank you for viewing the detailed overview of Aflac's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Aflac Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Aflac Inc (BSP:A1FL34) » Definitions » Research & Development
Comparable Companies
MET PRU UNM GL PRI JXN LNC FG CNO BHF SHSE:601318 SHSE:601628 HKSE:01299 BOM:543526 TSX:MFC SHSE:601601 TSX:GWO TPE:2881 LSE:PRU TSE:8750
Traded in Other Exchanges
AFL:USA 0H68:UK AFL:Germany
Address
1932 Wynnton Road, Columbus, GA, USA, 31999
Website
https://www.aflac.com
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Aflac Headlines

No Headlines